Skip to main content

Peer Review reports

From: A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

Original Submission
7 Jun 2013 Submitted Original manuscript
4 Jul 2013 Reviewed Reviewer Report - GILBERTO FILACI
6 Jul 2013 Reviewed Reviewer Report - Miriam Reuschenbach
22 Jul 2013 Author responded Author comments - Masanori Noguchi
Resubmission - Version 2
22 Jul 2013 Submitted Manuscript version 2
22 Aug 2013 Reviewed Reviewer Report - GILBERTO FILACI
28 Aug 2013 Reviewed Reviewer Report - Miriam Reuschenbach
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
3 Sep 2013 Editorially accepted
30 Dec 2013 Article published 10.1186/1471-2407-13-613

You can find further information about peer review here.

Back to article page